21:28 , Apr 18, 2019 |  BC Extra  |  Financial News

RNA-targeting small molecule company Arrakis raises $75M series B

Arrakis raised $75 million in a series B round led by venBio and Nextech Invest. Also participating were new investors Omega Funds, HBM Healthcare Investments, GV, WuXi AppTec Co. Ltd. (Shanghai:603259; HKSE:2359) and Alexandria Venture...
11:00 , Apr 18, 2019 |  BioCentury  |  Finance

Arranging Arrakis' syndicate

As it raised a $75 million series B round that will help its early research coalesce into a preclinical pipeline, Arrakis sought an investor syndicate that would build its expertise as it seeks to become...
16:29 , Apr 2, 2019 |  BC Extra  |  Financial News

Ocular oncology play Aura raises $40M D round

Medicxi led a $40 million series D round for Aura as the ocular oncology company prepares its lead choroidal melanoma therapy for Phase III testing in 1H20. The funding will give Aura Biosciences Inc. (Cambridge,...
18:06 , Aug 31, 2018 |  BC Week In Review  |  Financial News

Longitude joins syndicate for women's health play KaNDy's £25M series C

KaNDy Therapeutics Ltd. (Stevenage, U.K.) raised £25 million ($31.9 million) in a series C round on Aug. 29. New investor Longitude Capital joined existing investors Advent Life Sciences, Fountain Healthcare Partners, Forbion Capital Partners and...
20:59 , Aug 29, 2018 |  BioCentury  |  Finance

Sweetening the pot

KaNDy Therapeutics Ltd. believes its first venture round as an independent company will fund development of a non-hormonal therapy for menopausal symptoms that will be ready for a Phase III trial by 2020. Longitude Capital...
06:00 , Aug 29, 2018 |  BC Extra  |  Financial News

Longitude joins syndicate for women's health play KaNDy's £25M series C

KaNDy Therapeutics Ltd. (Stevenage, U.K.) raised £25 million ($31.9 million) in a series C round. New investor Longitude Capital joined existing investors Advent Life Sciences, Fountain Healthcare Partners, Forbion Capital Partners and OrbiMed in the...
02:27 , May 25, 2018 |  BC Extra  |  Financial News

Anti-infectives play Iterum raises $80M in IPO

Iterum Therapeutics plc (NASDAQ:ITRM) raised $80 million late Thursday through the sale of 6.2 million shares at $13 in an IPO underwritten by Leerink, RBC Capital Markets, Guggenheim and Needham. The price values Iterum at...
21:15 , May 18, 2018 |  BioCentury  |  Finance

China comes to Europe

  The historically underfunded European biotech sector is in the early stages of tapping into a new stream of capital thanks to the explosion of biomedical innovation in China, which has spawned a wave of...
17:08 , Apr 6, 2018 |  BC Week In Review  |  Financial News

Macrolide raises $20M

Macrolide Pharmaceuticals Inc. (Watertown, Mass.) raised $20 million on April 2 in a venture round led by existing investors Advent Life Sciences, Gurnet Point Capital, Novartis Venture Fund, Roche Ventures and SR One. The antibiotic...
18:48 , Apr 2, 2018 |  BC Extra  |  Financial News

Antibiotic play Macrolide raises $20M, names Karande CEO

Macrolide Pharmaceuticals Inc. (Watertown, Mass.) raised $20 million on Monday in a venture round led by existing investors Advent Life Sciences, Gurnet Point Capital, Novartis Venture Fund, Roche Ventures and SR One. The antibiotic company...